SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-002980
Filing Date
2022-02-10
Accepted
2022-02-10 14:09:36
Documents
58
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20211231_10q.htm   iXBRL 10-Q 1029422
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_331214.htm EX-31.1 13555
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_331215.htm EX-31.2 15595
4 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_331216.htm EX-32.1 9510
5 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_331217.htm EX-32.2 7362
  Complete submission text file 0001437749-22-002980.txt   5246711

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inbp-20211231.xsd EX-101.SCH 45726
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20211231_cal.xml EX-101.CAL 40048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20211231_def.xml EX-101.DEF 315338
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20211231_lab.xml EX-101.LAB 276149
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20211231_pre.xml EX-101.PRE 336596
52 EXTRACTED XBRL INSTANCE DOCUMENT inbp20211231_10q_htm.xml XML 917784
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 22613097
SIC: 2834 Pharmaceutical Preparations